BL-1030

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBL-1030
Drug Alias NameRX-111BL-1030
ClassificationSmall molecules
Mechanisms of ActionLeukocyte adhesion inhibitorsLeukocyte adhesion molecule-1 inhibitorsLeukocyte infiltration inhibitors
TargetsLeukocyte adhesion molecule-1
Therapy Area/IndicationsInflammationInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRimonyx Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdRimonyx Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsInflammationInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A